Tina Tzee Ling Howden

Title: Tina Tzee Ling Howden: Innovations in Ocular Drug Delivery

Introduction

Tina Tzee Ling Howden is an accomplished inventor based in Singapore, with a significant contribution to the fields of ophthalmology and drug delivery systems. With a total of two patents, Tina has focused his research on enhancing treatment methodologies for anterior segment eye diseases.

Latest Patents

Tina's latest patents include groundbreaking innovations in drug delivery technologies. The first patent is for "Nanoliposomes for sustained delivery of tacrolimus for treatment of anterior segment eye diseases." This patent details the use of nanoliposomes constructed from unsaturated and/or saturated lipids, which encapsulate the hydrophobic drug tacrolimus. The formulation aims to provide an effective method for the prophylaxis and treatment of ocular diseases affecting the anterior segment.

His second patent, titled "Hyaluronic acid-based drug delivery systems," introduces novel hyaluronic acid hydrogels that contain drug-loaded vesicles. These hydrogels offer sustained release formulations and have applications across various clinical domains, particularly in ophthalmology for conditions like glaucoma and other eye diseases. They are also applicable in treating dermatological conditions, showcasing a versatile approach to drug delivery.

Career Highlights

Throughout his career, Tina Tzee Ling Howden has worked with esteemed institutions such as Nanyang Technological University and Singapore Health Services Pte Ltd. His roles in these organizations have allowed him to focus on research and development in innovative drug delivery systems, leveraging his expertise in both pharmacology and biomedical engineering.

Collaborations

During his research journey, Tina has collaborated with notable colleagues, including Subramanian Venkatraman and Leonardus Kresna Widjaja. These collaborations have fostered advancements in innovative treatments and have expanded the potential applications of his inventions.

Conclusion

Tina Tzee Ling Howden stands out as a prominent inventor in Singapore, making substantial contributions to innovative drug delivery systems that address critical ocular health issues. His patents reflect a dedication to improving patient outcomes through sustained delivery methods, and his collaborations with other experts further enrich his impactful research. As he continues to innovate, the medical field eagerly anticipates the advancements stemming from his work.